Home > Quotes > SAGE
SAGE

Sage Therapeutics, Inc. Common Stock Quote & Summary Data

$37.92
*  
1.18
3.21%
Get SAGE Alerts
*Delayed - data as of Apr. 28, 2016  -  Find a broker to begin trading SAGE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    SAGE After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Sage Therapeutics, Inc. Common Stock Intraday Chart




Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 38.95 $ 89.035
Low $ 36.245 $ 26.2801

The current last sale of $37.92 is 44.29% Higher thanthe 52 week low.

P/E Ratio

ETFs with SAGE as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
0% BioShares Biotechnology Clinical Trials Fund (BBC) -10.73 (-34.35%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

We are a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening central nervous system, or CNS, disorders, where there are inadequate or no approved existing therapies. We are targeting CNS indications where patient populations are easily identified, clinical endpoints are well-defined, and development pathways are feasible. Our lead product candidate is SAGE-547, a proprietary intravenous formulation of allopregnanolone, a naturally occurring neurosteroid that acts as a synaptic and extrasynaptic modulator of the GABAA receptor. GABA is the major inhibitory neurotransmitter in the CNS, and mediates downstream neurologic and bodily function via activation of GABAA receptors.  ... More ...  

Risk Grade

Where does SAGE fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?